Company · CIK 0001570562 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Evolus, Inc. · EOLS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 SForm 4 → | Sep 4, 7:04 pm EDT | David MoatazediSee Remarks, Director | 105,108 | $9.04 | $950,019 | 499,592 | −17.4% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.